Get Patent Opposition Report for Avencell Europe

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Avencell Europe against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2651442Universal Anti-Tag Chimeric Antigen Receptor-Expressing T Cells And Methods Of Treating CancerUNIVERSITY OF MARYLANDJan 20, 2021